However, as with any prescription medication, they can come with side effects, and should only be used in very specific circumstances, and under careful clinical supervision
SURMOUNT-5 was a 72-week, open-label, Phase 3b randomised trial of 751 adults with obesity but without diabetes, comparing maximum-tolerated tirzepatide (10 or 15 mg) against maximum-tolerated semaglutide (1.7 or 2.4 mg)
They can also help you decide whether semaglutide is the right fit or if it may be beneficial to switch to another type of weight loss medication that your body may tolerate better
Semaglutide offers a promising option for individuals seeking to effectively manage type 2 diabetes and control weight, especially when standard medications are not sufficient
Semaglutide vs Tirzepatide: Comparing Weight-Loss Injections Semaglutide vs tirzepatide is a common comparison because both are weekly injectable medicines used to support weight loss alongside diet and lifestyle changes